Fundraising Fox
SV Health Investors
Venture capitalParent of1 affiliated firmDementia Discovery
London · Seed–Late Stage · 88 people tracked
Also known as SV HEALTH INVESTORS, LLC · SV HEALTH MANAGERS LLP
Find your way into SV Health Investors
Each arrow is one introduction. Sign up to fill in the first one.
Ask Diane K. Jorkasky, M.D. to introduce you to Nikola Trbovic
You →Diane · together at Complexa Inc. →Nikola
Ask Jamie Chen to introduce you to Christian Jung
You →Jamie · together at LoQus23 →Christian
Ask Sam Okafor to introduce you to Michael Balmuth
You →Sam · together at EPIVAX, INC. →Michael
- Greg Madden458 people can intro you
- Paul LaViolette379 people can intro you
- Tom Flynn377 people can intro you
Sign up to find every way you can get introduced to SV Health Investors
- Your email: who you already know at SV Health Investors, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SV Health Investors team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
SV Health Investors focuses exclusively on healthcare, aiming to transform the sector one investment at a time by backing diverse entrepreneurs building breakthrough companies and treatments. Its platform operates three teams: Therapeutics (including a dedicated dementia focus), Healthcare Growth, and Medtech, spanning all stages from early-stage biotech to growth capital and liquidity for industry leaders. The firm emphasizes creating healthcare companies that attract strategic acquirers and public investors while improving patients' lives. With a multi-decade track record across the US and UK, SV combines experienced investment professionals with healthcare industry veterans and operating partners to build value in life sciences companies.
Source: firm website, verified Sep 29, 2026.
Team · 88 people
from the firm's website & curated & public directories
Founder mafia
The SV Health Investors mafia →7 people who came through SV Health Investors went on to found or lead other companies.
What they invest in
from 112 of 237 portfolio companiesHealthtech ×79Biotech ×71Medical Devices ×50Digital Health ×28Deep Tech ×22AI & Machine Learning ×17Hardware ×10Longevity ×7
HQs:United States×75United Kingdom×10Canada×1Germany×1Ireland×1
Who they back
founder profiles across 44 portfolio companiesFounding team size:solo founder×232 founders×143 founders×24+ founders×5
Where their founders studiedfrom 44 founders with education data
University of California, Berkeley ×4University of Cambridge ×4Dartmouth College ×3Harvard University ×2Massachusetts Institute of Technology ×2Stanford University ×2The Hebrew University of Jerusalem ×2The Wharton School ×2
What their founders studiedfrom 40 founders with field-of-study data
Engineering ×13Life Sciences ×11Medicine ×8Economics ×4Computer Science ×3Finance & Accounting ×3Business & Management ×2Chemistry ×2
Where their founders worked beforefrom 46 founders with career history
GlaxoSmithKline ×3University of Oxford ×3Alzheimer's Research UK ×2Avizia ×2BioInnovate Ireland ×2Dementia Discovery ×2Faculty ×2Goldman Sachs ×2
23 founders hold a PhD · 5 hold an MBA (of 43 with degree data)
Investments · 237 tracked
founders shown can be your intro pathBy year:2026 · 62025 · 72024 · 52022 · 82020 · 32019 · 72018 · 42017 · 12016 · 62015 · 22014 · 52013 · 262 dated
AdaptHealth provides home healthcare supplies and services, delivering equipment for sleep apnea (CPAP/PAP), respiratory and breathing support, mobility, and diabetes care directly to patients' homes.
Digital HealthHealthtechMedical Devices
Suzanne Foster(Chief Executive Officer)in
Co-investorsOne Equity Partners
Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration.
AI & Machine LearningBiotechHealthtechLongevityMedical DevicesSan Francisco, US
Arnon Rosenthal(Ph.D.)inTillman Gerngross(Director)
BoardCarl Gordon(Director)Terry McGuire(Director)in
Co-investorsForesite CapitalGV (Google Ventures)Mission Bay CapitalMission BiocapitalMRL Ventures FundPolaris Partners
American Well operates a digital healthcare platform that connects patients, physicians, and healthcare professionals to provide remote clinical services, earning revenue through arrangements with healthcare organizations and clients who use its technology to deliver telehealth and related services.
HealthtechBoston, US
Ido Schoenberg(Executive Officer, Director)inRoy Schoenberg(Executive Officer, Director)inJames Malone(Executive Officer)inBradford F. Gay(Executive Officer)Phyllis Gotlib(President, International)inMark Hirschhorn(Executive Vice President, Chief Financial Officer and Chief Operating Officer)in
Co-investorsHanaco Venture CapitalMartin VenturesSV Life Sciences
Bicycle Therapeutics develops precision-guided therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, designed to penetrate deep into tissues and target intractable solid tumor cancers.
BiotechHealthtechCambridge, GB
Gregory Winter(Director)inNIGEL CROCKETT(Executive Officer)inNICHOLAS KEEN(Executive Officer)SANTIAGO ARROYO(Executive Officer)inMICHAEL HANNAY(Executive Officer)MICHAEL SKYNNER(Executive Officer)in
Co-investorsAhren Innovation CapitalAstellas Venture Management LLCCambridge Innovation CapitalDementia Discovery FundLongwood FundRidgeback Capital+4 more
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+20 more
Insulet develops the Omnipod, a tubeless, wearable, disposable insulin delivery Pod, along with automated insulin delivery systems for people managing insulin-dependent diabetes.
Digital HealthHardwareHealthtechMedical DevicesActon, US
Ashley A. McEvoy(Director, President and Chief Executive Officer)inFlavia Pease(Executive Vice President and Chief Financial Officer)inEric Benjamin(Executive Vice President, Chief Operating Officer)inLisa Blair Davis(Senior Vice President, Chief Human Resources Officer)inMichael H. Panos(Executive Vice President, Chief Commercial Officer)
Co-investorsWinklevoss Capital
Pulse Biosciences develops and commercializes ablation systems based on nanosecond pulsed-field ablation technology to treat medical conditions including benign skin lesions, soft tissue tumors, and cardiac arrhythmias.
BiotechBurlingame, US
Brian B. Dow(Executive Officer)Darrin R. Uecker(Executive Officer, Director)Amy Wang(Executive Officer, Director)Paul A. LaViolette(President and Chief Executive Officer)
BoardMaky Zanganeh(Director)Christopher Marlett(Director)
Sutro is a biotech company developing a cell-free protein synthesis platform for the design and manufacturing of complex biologics, particularly cancer therapies and antibody-drug conjugates.
BiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
William J. Newell(Executive Officer, Director)Jane Chung(Chief Executive Officer)inHans-Peter Gerber(Chief Scientific Officer)inDavid Pauling(Chief Administrative Officer and General Counsel)inJonathan Fawcett(VP, Head of Clinical Development)inDevendra Luhar(SVP, Technical Operations)in
Co-investorsOwl CapitalRidgeback CapitalSamsara BioCapitalSolasta VenturesVida Ventures
Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.
BiotechHealthtechWaltham, US
René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)
Co-investorsBain Capital Life SciencesBay City CapitalF-Prime CapitalM VenturesMRL Ventures FundRA Capital+9 more
SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease.
AI & Machine LearningDeep TechHealthtechMedical DevicesBedford, US
Eman Namati(President & CEO)inGuillermo Tearney(Founder; Professor of Pathology, Massachusetts General Hospital)Gregg Stone(Founder; Professor of Medicine, Mount Sinai Heart Health System)James Muller(Founder; Cardiologist, Brigham and Women's Hospital)inJeffrey O'Donnell(Founder; Managing General Partner, Runway Healthcare)Vivek Walimbe(Chief Operating Officer)in
Board seatPaul LaViolette· per SEC Form D
Co-investorsLumira VenturesS3 VenturesDeerfield Management CompanyJohnson & Johnson Innovation – JJDC
Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.
AI & Machine LearningBiotechDeep TechHealthtech
Jane Osbourn(Founder)Young Kwon(Founder)
Co-investorsRA CapitalDCVC BioDementia Discovery FundLightstone VenturesOno Venture Investment, Inc.British Business Bank+3 more
Draig develops neuropsychiatric therapies targeting glutamate and GABA pathways through AMPA and GABAA receptor modulators, serving patients with neuropsychiatric disorders.
BiotechDeep TechDigital HealthMedical DevicesCardiff, GB
John Atack(Head of Biology & Founder)inSimon Ward(Chief Scientific Officer & Founder)in
PartnerCharles Dunn· led
Co-investorsAccess BiotechnologyCanaan PartnersSanofi VenturesSR One Capital ManagementBritish Business BankJanus Henderson Investors
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Greg Lazar, Ph.D.(Co-Founder and Chief Scientific Officer)Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)in
BoardAlicia Levey(Director)
Co-investorsQiming Venture PartnersVersant VenturesAlexandriaDementia Discovery FundQiming HealthcareQiming Venture Partners USA
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices
Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in
Co-investorsGenesys CapitalToronto Innovation Acceleration Partners
Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform.
BiotechDeep TechMedical Devices
George Kassiotis(Co-founder)Drew Pardoll(Co-founder)Houman Ashrafian(Co-founder)in
Co-investorsRA CapitalPfizer VenturesSamsara BioCapitalDementia Discovery FundM VenturesPfizer Venture Investments
Harness Therapeutics develops disease-modifying precision therapies for hard-to-treat neurodegenerative diseases through controlled modulation of CNS targets.
BiotechHealthtech
Jan Thirkettle(CEO Director)in
Co-investorsEpidarex CapitalOno Venture Investment, Inc.Dementia Discovery Fund
Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.
AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB
Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)inSoumya Raychaudhuri(Founder)David A. Tuveson(Founder)Lindsey Rolfe(Chief Medical Officer)in
Co-investorsGV (Google Ventures)ForbionJohnson & Johnson Innovation – JJDCNorthpond VenturesJJDC
NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's.
BiotechHealthtechLongevity
Neil Miller(CEO)inRichard Rutter(CSO)inGrant Hawthorne(COO)inClaus Sundgreen(Chief Medical Officer)inPaul Thompson(CDO)in
BoardJonathan Savidge(Independent Non Executive Chair)
Co-investorsCriteria Bio VenturesNovartis Venture FundBritish Business BankM VenturesDementia Discovery FundOmega Funds
Packaging Compliance Labs is an industry leader providing sterile packaging solutions, design validation, and contract packaging services for medical device and life sciences manufacturers.
Advanced ManufacturingEnterprise SoftwareMedical DevicesSaaSGrand Rapids, US
Matthew Lapham(CEO & Co-Founder)in
Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism.
BiotechDeep TechHealthtech
Co-investorsLongwood FundOxford Science EnterprisesSofinnova PartnersDementia Discovery Fund
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesAngelini VenturesDementia Discovery FundDolby Family VenturesMitsui Global Investment+2 more
TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.
BiotechDeep TechLongevityMedical DevicesCambridge, GB
Damian Crowther, PhD FRCP(Co-founder, Head of Research)Dr. Leo James(Co-founder, Group Leader at MRC Laboratory of Molecular Biology)Dr. William McEwan(Co-founder, Group Leader at UK Dementia Research Institute, University of Cambridge)Nicki Thompson, PhD(CEO)Nicki Thompson(CEO)
Co-investorsCambridge Innovation CapitalPfizer VenturesM VenturesPfizer Venture InvestmentsStart CodonDiamond Edge Ventures
Axon Therapies develops the SAVM procedure, an implant-free catheter-based ablation therapy that targets the right greater splanchnic nerve to reduce overactive sympathetic nerve activity in patients with heart failure with preserved ejection fraction (HFpEF).
HealthtechMedical DevicesNew York, US
Howard R. Levin(Executive Officer, Director)Mark Gelfand(Executive Officer)
Board seatPaul LaViolette· per SEC Form D · $2M raise · filed Apr 2016
Co-investorsStar51 CapitalAction Potential Venture Capital Ltd.Deerfield Management CompanyEarlybird Venture Capital
BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.
Digital HealthHealthtechMedical DevicesSeattle, US
Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)
Board seatPaul LaViolette· per SEC Form D
Co-investorsAPERTURE Venture PartnersAphelion CapitalAscension VenturesLumira VenturesRC CapitalRex Health Ventures+2 more
CardioFocus develops Pulsed Field Ablation (PFA) technologies and systems for electrophysiologists to treat complex cardiac arrhythmias with precision and control.
BiotechHealthtechMedical DevicesMarlborough, US
Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)inAnjie Roldan(Executive Officer)inWarren R. Clark III(Executive Officer)Stephan S. Ogilvie(CEO)in
Board seatPaul LaViolette· per SEC Form D
Co-investorsBioBritSaints CapitalAccuitive Medical VenturesOxford Bioscience PartnersSV Life Sciences
Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
BiotechTewksbury, US
George J. Fazio(Executive Officer, Director)inDan B. Curtis(Executive Officer)
BoardKevin Gillis(Director)inGerald Brunk(Director)inIrit Yaniv(Director)in
Board seatPaul LaViolette· per SEC Form D · $11.1M raise · filed Jun 2025
Co-investorsAccelmed PartnersLumira VenturesGeneral CatalystThird Rock Ventures
.png)
RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis.
HealthtechMedical DevicesLutherville, US
Ellen Sheets(Executive Officer, Director)inIan J. Vawter(Executive Officer)Steven Schaefer(Executive Officer)inWilliam Floyd(Executive Officer, Director)inVincent Owens(Director)Richard Kent(Director)
Board seatPaul LaViolette· per SEC Form D
Co-investorsAscension VenturesFirst AnalysisNew Markets Venture PartnersBlue Heron CapitalTVM CapitalTVM Capital Life Science
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Board seatPaul LaViolette· per SEC Form D
Co-investorsAPERTURE Venture PartnersBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSeroba Life Sciences+1 more
Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables.
Digital HealthHealthtechMedical DevicesMinneapolis, US
Mark Christopherson(Executive Officer, Director)inHoward Levin(Director)
BoardDavid Neustaedter(Director)inMichael Hurley(Director)
Board seatPaul LaViolette· per SEC Form D
Ocular Therapeutix focuses on drug development and treatment for retinal diseases, with an emphasis on wet age-related macular degeneration and expanding into diabetic retinopathy conditions.
BiotechDigital HealthHealthtechMedical DevicesBedford, US
Amarpreet Sawhney(Director)Kevin Hanley(Executive Officer)Michael Goldstein(Executive Officer)inDaniel Bollag(Executive Officer)Antony Mattessich(Executive Officer, Director)inDonald Notman(Executive Officer)in
Board seatCharles Warden· per SEC Form D
Co-investorsAscension VenturesSofinnova VenturesTop Corner CapitalAgent Capital
BiotechHealthtechPompano Beach, US
Laura Tyler Perryman(Director)Regina Groves(Executive Officer, Director)Virginia Sullivan(Executive Officer)Marc Loev(Director)Richard Chen Mao(Director)Gary Perryman(Director)
Board seatPaul LaViolette· per SEC Form D · $8M raise · filed Sep 2020
Co-investorsEmergent Medical Partners, LLP
Asensus Surgical (formerly TransEnterix) develops robotic-assisted surgical systems and augmented intelligence technology, including reusable instruments, to give surgeons real-time information during procedures.
AI & Machine LearningHealthtechMedical DevicesRoboticsMorrisville, US
Anthony Fernando(Executive Officer)inTodd M. Pope(Executive Officer, Director)inJoseph P Slattery(Executive Officer)inJames J. Martin(Executive Officer)Charles J. Filipi(Executive Officer, Director)Jeffrey G. Spragens(Executive Officer, Director)
Board seatPaul LaViolette· per SEC Form D
Co-investorsAisling CapitalSaints CapitalQuaker BioVenturesSV Life Sciences
BiotechMaple Grove, US
JON PATRICK ST. GERMAIN(Executive Officer)DAVID KRENN(Executive Officer)JOHANN NEISZ(Executive Officer, Director)
BoardMARY LINCOLN CAMPBELL(Director)MITCHELL DANN(Director)PAUL A. LAVIOLETTE(Director)in
Board seatPaul LaViolette· per SEC Form D
Co-investorsKaiser Permanente Ventures
Achillion conducts research and development focused on addressing rare disease challenges through investigation of new therapeutic targets, modalities, and technologies.
BiotechHealthtech
Co-investorsConnecticut InnovationsPappas CapitalDomain Associates
Adimab develops proprietary platforms for antibody and protein therapeutic discovery, engineering fully-functional immunoglobulins in a controllable in vitro eukaryotic system.
AI & Machine LearningBiotechDeep TechVermont, US
Co-investorsGrandBanks CapitalLaunchCapitalLux CapitalMithril Capital ManagementPremji InvestOrbiMed+1 more
AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)inPhilina Lee(Executive Officer, Director)inAaron Pickett(Executive Officer)in
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Co-investorsBain Capital Life SciencesCatalio Capital Management, LPProto AxiomSanofi VenturesTenmileAbingworth+2 more
Ally Bridge Group is a healthcare investment management firm investing across the global life sciences industry through complementary private equity and public equity strategies.
BiotechHealthtechMedical DevicesNew York, US
Frank Yu(Founder, Chief Executive Officer, Chief Investment Officer)in
Alpheus is a clinical-stage biotechnology company developing Porphyrin Metabolite Activation (PoMA™), a drug-led oncology approach designed to treat glioblastoma using proprietary low-intensity ultrasound to activate tumor-localized porphyrin metabolites.
BiotechHealthtechMedical DevicesChanhassen, US
Jeremy Ling(Executive Officer)inSteve Weiner(Executive Officer)Vijay Agarwal(Founder, President and CEO)inWilliam Davis(Executive Officer, Director)
BoardKlaus Veitinger(Director)inImran Eba(Executive Officer)in
Co-investorsOrbiMedHealthQuest CapitalSamsara BioCapitalAction Potential Venture Capital Ltd.BrightEdge
Amphista Therapeutics develops next-generation targeted protein degradation (TPD) medicines using its proprietary Targeted Glue technology, which is engineered to selectively trigger the destruction of disease-causing proteins.
BiotechCambridge, GB
Louise Modis(Chief Executive Officer)inMartin Pass(Chief Development Officer)inGiles Brown(Executive VP Drug Discovery)in
Co-investorsAdvent Life SciencesNovartis Venture FundDementia Discovery FundEuropean Investment FundForbionGilde Healthcare+2 more
The site presents ICON, a clinical research organization providing full-service drug development outsourcing, regulatory strategy, and clinical trial solutions for pharmaceutical and biotech sponsors.
AI & Machine LearningBiotechHealthtech
Co-investorsHalifax Group
Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersDementia Discovery FundM VenturesNovartis Venture FundPfizer Venture InvestmentsRA Capital+6 more
AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics.
BiotechDeep TechHealthtechLongevityMedical Devices
Jane Rhodes(Chief Executive Officer)inMagnus Ivarsson(Chief Scientific Officer)inHannah Pearce(Chief Operating Officer)inMichelle L. Mellion(Chief Medical Officer)in
.jpg)
Co-investorsDementia Discovery FundMPM BioImpactNovartis Venture FundUCL Technology FundAlbionVC
Autifony Therapeutics is a privately funded biopharmaceutical company developing treatments for neurological conditions including Fragile X Syndrome and orphan epilepsy syndromes.
BiotechHealthtechMedical DevicesStevenage, GB
Charles H. Large(Founder and Chief Executive Officer)Giuseppe Alvaro(Director)Daniel UmbrichtBarbara Domayne-HaymanMartin GunthorpeHannah Selin
Co-investorsPfizer Venture InvestmentsDementia Discovery FundInnovate UK
AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
BiotechDeep TechDigital HealthHealthtech
Chris Shaw(Co-Founder & Chief Scientific and Clinical Advisor)inDo Young Lee(Co-Founder)Youn Bok Lee(Co-Founder)inLisa Deschamps(Chief Executive Officer)inGraeme Fielder(Chief Operating Officer)inAlex Bloom(Chief Development Officer)in
Co-investorsAdvent Life SciencesDementia DiscoveryF-Prime CapitalLifeArc VenturesMonograph Capital PartnersNew Enterprise Associates (NEA)
Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.
BiotechHardwareMedical DevicesLebanon, US
Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)
Co-investorsOrbiMedBorealis VenturesMithril Capital ManagementNeomed ManagementPolaris PartnersSands Capital Ventures+1 more
AVROBIO develops ex vivo lentiviral vector-based hematopoietic stem cell gene therapies to treat lysosomal disorders by permanently integrating therapeutic genes into patient stem cells manufactured outside the body.
BiotechDigital HealthHealthtechMedical Devices
Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration.
BiotechMedical Devices
Charles Sidoti(Founder)in
Co-investorsAngel Physicians FundCatalyst Health VenturesExcelestar VenturesFemHealth VenturesSchooner CapitalSparta Group
Caraway Therapeutics was a preclinical biopharmaceutical company developing small-molecule therapies modulating lysosomal function to treat neurodegenerative and rare diseases.
BiotechHealthtech
Co-investorsDementia Discovery FundEisai Innovation, Inc.McCarthy CapitalMRL Ventures FundAbbVieBridge Investments+9 more
CarePredict offers a platform that detects patterns in the daily activities of older adults to signal health changes and enable early intervention.
AI & Machine LearningDigital HealthHealthtechLongevityPlantation, US
Satish Movva(Founder)inPeter Livingston(Director)Dean Hatton(Director)inMarc Loev(Director)
Co-investorsHealthtech CapitalLas Olas Venture CapitalVillage GlobalMiami Angels
Celerion is a contract research organization specializing in early phase clinical drug development, providing bioanalytical services and laboratory testing that generate clinical data for pharmaceutical clients.
BiotechDigital HealthHealthtechMedical DevicesLincoln, US
Co-investorsAea InvestorsBain Capital VenturesH.I.G. CapitalH.I.G. HealthBridge Partners
Centauri provides data-driven technology and services for U.S. health plans and health systems, turning fragmented clinical data into analytics used for risk adjustment, care coordination, quality optimization, and clinical data exchange.
Data & InfrastructureDigital HealthHealthtech
Mike McNelis(Founder)in
Co-investorsABRY PartnersDementia Discovery FundSilversmith Capital Partners
Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in
Co-investorsDementia Discovery FundForesite CapitalGV (Google Ventures)SV Life SciencesDementia DiscoveryDolby Family Ventures+3 more
Cumulus manufactures a cold coffee brewing machine that produces cold brew, nitro, and cold espresso on demand, sold direct to consumers alongside specialty coffee capsules and accessories.
ConsumerHardware
Mesh Gelman(Founder)in
Co-investorsMaveronBrick Mortar VenturesInvesting Women AngelsShell Ventures
EMED makes infusion pump systems and subcutaneous delivery devices for patients requiring immunoglobulin therapy and other biologics.
Digital HealthHardwareHealthtechMedical Devices
Phil Parvin MBAin
EpiVax works with biologic and vaccine developers to assess and manage immunogenicity risk across the product lifecycle, combining in silico analysis with in vitro testing to produce actionable immunogenicity data.
AI & Machine LearningBiotechHealthtech
Annie De Groot MD(Founder)inRich-Henry Schabowsky, PhD, JDin
BiotechCambridge, US
Jennifer Glennon(Executive Officer)inBalkrishan (Simba) Gill, Ph.D.(Executive Officer, Director)Duncan McHale(Executive Officer)inWilliam DeVaul(Executive Officer)inMark Bodmer, Ph.D.(Executive Officer)
BoardNoubar B. Afeyan, Ph.D.(Director)
Co-investorsGV (Google Ventures)AlexandriaFlagship PioneeringKaiser Permanente VenturesMayo Clinic Ventures
Evidation collects and analyzes real-world health data from millions of community members to enable clinical research and health programs across various medical conditions.
BiotechData & InfrastructureDigital HealthHealthtechSan Francisco, US
Christine Lemke(Executive Officer, Director)inDeborah Kilpatrick(Executive Officer, Director)Leslie Oley Wilberforcein
BoardDavid Fleshman(Director)Rowan Chapman(Director)in
Co-investorsAsset Management CompanyB Capital GroupB4 CapitalCross Creek AdvisorsDementia Discovery FundFresco Capital+6 more
.jpeg){kind=logo}
EyeBio (Eyebiotech Limited), a subsidiary of Merck, develops therapies for retinal diseases such as diabetic macular edema and neovascular age-related macular degeneration, targeting vascular leakage through pathways like Wnt signaling.
BiotechHealthtechHolborn, London
David R. Guyer(Founder, CEO & President)Anthony P. Adamis(Chief Scientific Officer, Co-founder, Director & Chair of Advisory Board)James Allister John Costine(Director)Michael Jay Ross(Executive Officer)Catherine Elizabeth Bingham(Director)
Co-investorsJeito CapitalSamsara BioCapitalOmega Funds
Homecare Homebase (HCHB) offers a suite of AI and analytics extensions built into its home health and hospice software, providing reporting dashboards, patient intake, rehospitalization risk prediction, automated scheduling, and ambient clinical documentation.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaS
Dr. Martha Stuart Williams(Chief People Officer)Isaac(Vice President of Technology Operations)
Imbria Pharmaceuticals develops novel cardiovascular disease treatments that target cardiac energy metabolism, with a lead drug candidate, ninerafaxstat, in clinical trials for non-obstructive hypertrophic cardiomyopathy.
BiotechDigital Health
Alvin Shih(CEO)inAlbert M. Kim(Chief Medical Officer)in
Co-investorsAN Venture PartnersCatalio Capital Management, LPRA CapitalSanofi VenturesCatalio Capital Management
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.
BiotechHealthtechMedfield, US
Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)
Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesGimvSixty Degree Capital+3 more
Leal Therapeutics is a company focused on CNS (central nervous system) disorders, drawing on academic and drug-development experience in neurology and neurodegenerative disease.
BiotechHealthtechMedical DevicesWorcester, US
Asa Abeliovich(CEO & Founder, Director)
Co-investorsOrbiMedAbbVieDementia Discovery FundNewpath Partners
Leica Microsystems manufactures optical microscopy instruments and fluorescence reagents for scientific research and diagnostics.
BiotechDeep TechHardwareHealthtechMedical DevicesWetzlar, DE
Co-investorsArieal Southeast Angel Partners
Leiters Health is an FDA-registered 503B outsourcing facility that produces sterile compounded preparations for hospitals, surgery centers, and ophthalmic use.
BiotechHealthtechMedical DevicesDenver, US
Co-investorsCorewell Health VenturesDementia Discovery FundEscalate Capital PartnersFrazier Healthcare PartnersH.I.G. CapitalH.I.G. HealthBridge Partners+4 more
LoQus23 Therapeutics is a drug discovery company developing treatments for triplet repeat expansion diseases such as Huntington's disease, focused on preclinical CNS and neuroscience research.
BiotechDeep TechCambridge, GB
David Reynolds(Co-founder & CEO)inCaroline Benn(Co-founder & CSO)in
Co-investorsDementia Discovery FundNovartis Venture FundForbion
Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears.
HealthtechMedical DevicesWestborough, US
Martha Murray(Founder)inChris Joyce(Executive Officer)inPatrick McBrayer(Executive Officer, Director)inSean Sansiveri(Director)Pieter Wolters(Director)
BoardMarc-Andre Marcotte(Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersEndeavour Vision
Mindframe builds AI-powered technology for behavioral health practitioners to enhance clinical care delivery and patient engagement in regulated healthcare environments.
AI & Machine LearningDigital HealthHealthtechMental HealthLondon, GB
Pinar Gorgulu(CEO & Co-founder)inFaye Cheung, PhD(CTO & Co-founder)in
Co-investorsTechstars
Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)
Co-investorsBEVCDolby Family VenturesTwo Bear CapitalDementia Discovery FundKdT Ventures
Modern Systems Talk (MST) publishes content and insights on technology topics including system architecture, cloud computing, automation, AI, cybersecurity, and digital transformation.
Media & Entertainment
Co-investorsAgate Medical Investments LPSCP Vitalife PartnersForbionGV (Google Ventures)Northpond Ventures
Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health.
BiotechFemTechMedical DevicesCambridge, US
Alison Burklund(Executive Officer, Director)inAmogha Tadimety(Executive Officer, Director)in
BoardAaron Sandoski(Director)inJeff Crowe(Director)in
Co-investorsAlumni VenturesNorwest Venture PartnersService Provider CapitalUndeterred CapitalGingerbread CapitalGreen D Ventures+2 more
The NFLPA is the labor union representing players of the National Football League, working on their success and well-being both on and off the field.
Sports Tech
Nimbus develops wireless power technology that uses invisible infrared LED light to transmit energy across a room, with a receiver that converts the light into electricity to charge laptops, phones, and other devices.
Deep TechEnergyHardware
Michael Gorman(Founder)in
Co-investorsFoothill VenturesAccess BiotechnologyAtlas VentureBain Capital Life SciencesBiotechnology Value FundCommodore Capital+2 more
FuseBase is an enterprise platform for deploying and managing AI agents across teams with role-based access controls, audit trails, and integrations to CRM, Slack, Teams, and email systems.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSCleveland, US
Pavel Sher(CEO)Aaron Adsit(CRO)Denis Kibalko(CTO)
Co-investorsPre-Seed to SucceedYellow Rocks!Access BiotechnologyAtlas VentureBain Capital Life SciencesBiotechnology Value Fund+3 more
Nimbus Therapeutics is a biotechnology company that designs precision small molecule medicines using a computational, multidisciplinary drug discovery approach.
AI & Machine LearningBiotechDeep TechHealthtech
Co-investorsAccess BiotechnologyAtlas VentureBain Capital Life SciencesDementia Discovery FundGV (Google Ventures)Lightstone Ventures+4 more
Nira Medical consolidates independent neurology practices across the United States to improve patient access to neurological care.
Digital HealthHealthtechMedical Devices
Co-investorsSilversmith Capital PartnersTRANSFORMATION CAPITAL
Nitrase Therapeutics is a clinical-stage biopharmaceutical company using its NITROME platform to develop therapeutics based on nitrases, a class of enzymes it discovered that drive protein nitration.
BiotechHealthtechLongevity
Irene Griswold-Prenner(Founder & Chief Executive Officer)in
Co-investorsDementia Discovery FundMission BiocapitalSofinnova PartnersAbbVieMission Bay Capital
Nuwellis develops medical technology solutions for managing fluid overload in patients with cardiorenal conditions, serving clinicians and healthcare providers in inpatient and outpatient settings.
BiotechHardwareHealthtechMedical DevicesEden Prairie, US
Rob Scott(Executive Officer)inNestor Jaramillo, Jr.(Executive Officer, Director)inBrian Brown(Executive Officer)David A. Rosa(Executive Officer, Director)Claudia Drayton(Executive Officer)inDebra J. Kridner(Executive Officer)
Co-investorsAscension VenturesKaiser Permanente Ventures
Onkos Surgical develops limb salvage and orthopedic reconstruction implants and systems for treating musculoskeletal cancer and complex orthopedic conditions.
HardwareHealthtechMedical DevicesParsippany, US
Patrick Treacy(Founder)inAntony Koblish(Director, Promoter)inBrad Tyler(Executive Officer)in
BoardAdele Oliva(Director)inStephen Bloch(Director)inPaul Touhey(Director)
Co-investors1315 CapitalCanaan PartnersJSD Capital, LLCRocky Point Ventures
BiotechNew York, US
David Guyer(Executive Officer, Director)Glenn Sblendorio(Executive Officer, Director)Mike AtiehinDavid Redlick(Director)Keith Westby(Executive Officer)David Carroll(Executive Officer)
Co-investorsSofinnova VenturesClarus VenturesSV Life Sciences
BiotechMt. Arlington, US
Paul Chaney(Executive Officer, Director)
BoardAbbie Celniker(Director)inDavid Guyer(Director)Bruce Peacock(Director)Kevin Starr(Director)inLutz Giebel(Director)
Co-investorsAstellas Venture Management LLCAgent CapitalSV Life SciencesThird Rock Ventures
PayMedix simplifies healthcare payments by paying providers in full for allowed in-network claims and streamlining patient billing, improving access to care regardless of financial status.
Digital HealthEnterprise SoftwareFintechHealthtech
Tom Policelli(Chief Executive Officer)inBrian Marsella(President)in
Co-investorsHLM Investment Partners
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSeroba Life SciencesEnterprise IrelandEQT Life Sciences
Pivot Point Consulting provides managed IT services, EHR consulting, strategic advisory, analytics and AI solutions, and ERP implementation services to healthcare organizations.
AI & Machine LearningEnterprise SoftwareHealthtechSaaS
Podimetrics offers a remote monitoring and care program for people with complex diabetes, centered on the SmartMat device that collects foot-health data to enable early intervention and prevent complications such as amputations.
Digital HealthHealthtechMedical DevicesSomerville, US
David Linders(Executive Officer, Director)inJonathan Bloom(Executive Officer, Director)
BoardAaron Sandoski(Director)in
Co-investorsNorwich VenturesScientific Health DevelopmentPolaris PartnersRock Health
Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.
BiotechHealthtech
Pete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDavid Mantusin
Co-investorsAdjuvant CapitalAsahi Kasei Corporate Venture CapitalDementia Discovery FundF-Prime CapitalJeito CapitalLongwood Fund+4 more
Quell Therapeutics is a clinical-stage biopharmaceutical company developing targeted Treg cell therapies with advanced manufacturing capabilities.
BiotechDeep TechHealthtechMedical Devices
Co-investorsAlbionVCJeito CapitalUCL Technology Fund
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
Ria Health provides telemedicine-based treatment for alcohol and opioid use disorders, delivered by a team of physicians, nurse practitioners, and counselors.
Digital HealthHealthtechMental HealthWellness & FitnessSan Francisco, US
Bill Stapleton(CEO)in
Co-investorsSOSV
BiotechGreenville, US
Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)
Co-investorsHatteras Venture PartnersIllumina VenturesM VenturesMC Healthcare VenturesPappas CapitalAbbVie+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Direct Flow MedicalSkylitAccelecare HoldingsAeroCare Holdings, Inc.Affinium PharmaceuticalsAlantos PharmaceuticalsAligned Telehealth IncAllegiance Hospice GroupAllianceCareAllos Therapeutics IncAltura MedicalAqueSysArchemixArgonaut TechnologiesArsanisArsanis BiosciencesAtopix Therapeutics LimitedAuxilium PharmaceuticalsAxys PharmaceuticalsBicycle TherapeuticsBioAgeBioCore HoldingsBioCore Holdings (BioClinica)BroadlaneCadent TechnologiesCardiac Support SystemsCardioKinetixCardioMindCellutionsCellzome LimitedCentauri HoldingsCerebral Vascular ApplicationsCHF SolutionsCibiemCognis HoldingConcentric MedicalConfluent Surgical, Inc.Convergence PharmaceuticalsCoral TherapeuticsCoreLab PartnersCRI WorldwideDoctors of Physical TherapyDualitasEasyChemEndlyzEntellusErvaxx LimitedESBATechEunoeEuro DentalversandEuro Dentalversand HoldingEUSA PharmaEyeBioEyetech PharmaceuticalsGeltex PharmaceuticalsGeneral Surgical InnovationsGenosisGlycoFi IncHalscionHealth Payment SystemsHealthifyHeritage Health SystemsHighTop HealthIHG HoldingsIkano TherapeuticsImbria PharmaceuticalsIncyte PharmaceuticalsISG HoldingsJC NationwideJet HealthKalVista PharmaceuticalsKinetix PharmaceuticalsKuDOS PharmaceuticalsLenSx Lasers IncLeukoSite IncLipoSonixLoQus23 TherapeuticsMaestro HealthcareMdeverywhereMedNovaMestag TherapeuticsMicromassMicroMedMicromet IncMisonixMpex Pharmaceuticals IncMyOrthosNeoVistaNeurogeneusNexanNitrome BiosciencesNordic Consulting PartnersNovaLignOMS FoundationsOncoEthixOrchid ChemicalsOrthovitaPatient CarePelton & CranePhase ForwardPhysicians Dialysis Inc.PowderMed LtdPrileniaQuick Study RadiolRemita HealthRempex PharmaceuticalsRespiVert LtdRicerca BiosciencesRinat Neuroscience
Browse all 237 investments with full details →
▶37 more tracked companies
Robling Medical IncRondo TherapeuticsSadra MedicalSchweigerdermShire PharmaceuticalsSirona Dental SystemsSitryx Therapeutics LimitedSocios Mayores en SaludSoffio MedicalSolexa LtdSpectrum Professional ServicesSpinal KineticsSpineology IncStimwaveStrides ArcolabSudo BioSun Behavioral HealthSynarcThe Corner PharmacyTheddfundThesan PharmaceuticalsThird Wave TechnologiesTLC VisionTransine Therapeutics LtdTransposonTRexBioTrialScopeTriangle PharmaceuticalsTrimTechU S Renal CareUrgent TeamVersicorVibrato MedicalViolet Therapeutics, Inc.Vitalize Consulting SolutionsWellTheoryXimedica
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 17
10 IPOs · 7 acquisitions · showing 15AdaptHealthNASDAQ: AHCOAlectorNASDAQ: ALECAmerican WellNYSE: AMWLBicycleNASDAQ: BCYCBioAge LabsNASDAQ: BIOACytomed TherapeuticsNASDAQ: GDTCInsuletNASDAQ: PODDPulse BiosciencesNASDAQ: PLSESutrobioNASDAQ: STROXilio TherapeuticsNASDAQ: XLOAvitideacq. by RepligenCarawayacq. by MerckEyeBioacq. by MerckEyebiotechacq. by MerckMisonixacq. by Bioventus
Portfolio news
latest coverage across their companies
AdvanCell Isotopes · intelligence360.news · Aug 4, 2026
Draig Therapeutics · finsmes.com · Jul 14, 2026
Alchemab · trysignalbase.com · Jul 10, 2026
Enara Bio · scalingeurope.co.uk · Jun 2, 2026
Mestag · finsmes.com · Mar 17, 2026
Kinaset Therapeutics · finsmes.com · Jan 12, 2026
Fund performance · per public LP disclosures
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| SV Health Investors Growth Fund VII bLPs: New Mexico Educational Retirement Board | 2024 | — | 0.0% | 0.00x | 0.00x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
IPO stake values · per SEC filings · 2
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Sutrobio | 7.9% | $15.00 | Sep 2018 | $27.1M |
| American Well | — | $27.50 | Jan 2021 | $515.3K |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has SV Health Investors made?
- SV Health Investors has 237 tracked investments, 17 of which have exited, including 13 dated in the last 24 months.
- What stage does SV Health Investors invest at?
- SV Health Investors invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is SV Health Investors's typical check size?
- SV Health Investors typically writes checks of $1M – $20M.
- What sectors does SV Health Investors focus on?
- SV Health Investors focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is SV Health Investors located?
- SV Health Investors is headquartered in London, GB.
- Does SV Health Investors lead rounds?
- Yes, SV Health Investors leads investment rounds.
- Who does SV Health Investors co-invest with?
- SV Health Investors most often shares deals with Dementia Discovery Fund, Sanofi Ventures, RA Capital, among 164 tracked co-investors.
Media · Podcasts & interviews
featuring the teamMedtech Venture Capital Insights with Paul LaViolette of SV Health Investors
State of MedTech · Paul LaViolette
Co-investors · 28
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies aligned with Sanofi's mission of advancing human health.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Ascension Ventures manages capital and presents itself as an investor connected to a large health system network, referencing hundreds of acute care hospitals and a substantial employee base.
Third Rock Ventures is a venture capital firm that discovers, launches, and builds life sciences and biotechnology companies developing novel medicines and therapies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Dolby Family Ventures is an early-stage investment firm founded in 2014 that backs entrepreneurs tackling complex science and engineering challenges across precision neuroscience, life sciences platforms, aerospace, digital deep tech, and climate tech.
Omega Funds invests in venture capital and growth equity opportunities across the life sciences sector.
Lightstone Ventures is a life sciences venture firm founded in 2012 that invests in biotech and medtech companies, backing founders translating scientific breakthroughs into therapies and medical technologies.
▶16 more co-investors
Silversmith Capital PartnersAbingworth7wire VenturesNew Leaf Venture PartnersBain Capital VenturesB Capital GroupSOSVSummit PartnersPivotal Life SciencesAisling CapitalBorealis VenturesMcKesson VenturesUS Venture PartnersS32Sandbox IndustriesJUXTAPOSE VENTURES
Firms observed investing alongside SV Health Investors, from public investor directories. Shared companies are the overlap with SV Health Investors's recorded portfolio.
Funds & brands
Separately branded funds and arms of SV Health Investors. Each has its own page; people who work on a brand are listed on both.
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
Pontifax is a venture capital firm focused on life sciences and healthcare technologies, investing across all development stages from early-stage startups to clinical-stage growth companies.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.